Cite
Phase 1 Evaluation of 3 Highly Immunogenic Prime-Boost Regimens, Including a 12-Month Reboosting Vaccination, for Malaria Vaccination in Gambian Men.
MLA
Moorthy, Vasee S., et al. “Phase 1 Evaluation of 3 Highly Immunogenic Prime-Boost Regimens, Including a 12-Month Reboosting Vaccination, for Malaria Vaccination in Gambian Men.” Journal of Infectious Diseases, vol. 189, no. 12, June 2004, pp. 2213–19. EBSCOhost, https://doi.org/10.1086/421118.
APA
Moorthy, V. S., Imoukhuede, E. B., Keating, S., Pinder, M., Webster, D., Skinner, M. A., Gilbert, S. C., Walraven, G., & Hill, A. V. S. (2004). Phase 1 Evaluation of 3 Highly Immunogenic Prime-Boost Regimens, Including a 12-Month Reboosting Vaccination, for Malaria Vaccination in Gambian Men. Journal of Infectious Diseases, 189(12), 2213–2219. https://doi.org/10.1086/421118
Chicago
Moorthy, Vasee S., Egeruan B. Imoukhuede, Sheila Keating, Margaret Pinder, Daniel Webster, Michael A. Skinner, Sarah C. Gilbert, Gijs Walraven, and Adrian V. S. Hill. 2004. “Phase 1 Evaluation of 3 Highly Immunogenic Prime-Boost Regimens, Including a 12-Month Reboosting Vaccination, for Malaria Vaccination in Gambian Men.” Journal of Infectious Diseases 189 (12): 2213–19. doi:10.1086/421118.